Market Cap (In USD)
24.73 Million
Revenue (In USD)
1.07 Million
Net Income (In USD)
-14.24 Million
Avg. Volume
140.14 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.734-2.4
- PE
- -
- EPS
- -
- Beta Value
- -2.833
- ISIN
- US31447E1055
- CUSIP
- 31447E105
- CIK
- 1339005
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Ms. Kathy Lee-Sepsick M.B.A.
- Employee Count
- -
- Website
- https://www.femasys.com
- Ipo Date
- 2021-06-18
- Details
- Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
More Stocks
-
ZVSA
-
VSEEVSee Health, Inc.
VSEE
-
IDKOYIdemitsu Kosan Co.,Ltd.
IDKOY
-
GVR
-
002093Guomai Technologies, Inc.
002093
-
PRIO3Petro Rio S.A.
PRIO3
-
FFNT
-
MALEE